Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves
Author: ["Julia Alter","Fang Lou","Adam Rabinowitz","HaiFang Yin","Jeffrey Rosenfeld","Steve D Wilton","Terence A Partridge","Qi Long Lu"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
For the majority of Duchenne muscular dystrophy (DMD) mutations, antisense oligonucleotide (AON)-mediated exon skipping has the potential to restore a functional protein. Here we show that weekly intravenous injections of morpholino phosphorodiamidate (morpholino) AONs induce expression of functional levels of dystrophin in body-wide skeletal muscles of the dystrophic mdx mouse, with resulting improvement in muscle function. Although the level of dystrophin expression achieved varies considerably between muscles, antisense therapy may provide a realistic hope for the treatment of a majority of individuals with DMD.
Cite this article
Alter, J., Lou, F., Rabinowitz, A. et al. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 12, 175–177 (2006). https://doi.org/10.1038/nm1345
